Showing results (891-900 of 1,231) with videos related to

Sort By:
Pageof 124
Plos One|January 18, 2013
Insights into the genetic architecture of early stage age-related macular degeneration: a genome-wide association study meta-analysisElizabeth G Holliday, Albert V Smith, Belinda K Cornes, et al.
The Lancet. Oncology|September 16, 2021
Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trialPhilippe Moreau, Cyrille Hulin, Aurore Perrot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2021
Burkitt Lymphoma International Prognostic IndexAdam J Olszewski, Lasse H Jakobsen, Graham P Collins, et al.
Lancet (London, England)|June 8, 2019
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 studyPhilippe Moreau, Michel Attal, Cyrille Hulin, et al.
Blood Advances|February 22, 2021
Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trialBob Löwenberg, Thomas Pabst, Johan Maertens, et al.
Plos One|February 9, 2013
Genome-wide association study of retinopathy in individuals without diabetesRichard A Jensen, Xueling Sim, Xiaohui Li, et al.
Plos One|September 19, 2014
Genome-wide meta-analysis of myopia and hyperopia provides evidence for replication of 11 lociClaire L Simpson, Robert Wojciechowski, Konrad Oexle, et al.
Blood|July 15, 2020
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centersAndrew M Evens, Alexey Danilov, Deepa Jagadeesh, et al.
Leukemia|January 31, 2024
Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trialA A van de Loosdrecht, E M P Cremers, C Alhan, et al.
Communications Biology|December 14, 2020
Common variants in SOX-2 and congenital cataract genes contribute to age-related nuclear cataractEkaterina Yonova-Doing, Wanting Zhao, Robert P Igo, et al.
Pageof 124